rhc 3164 has been researched along with 2-methylquinoxaline in 1 studies
| Studies (rhc 3164) | Trials (rhc 3164) | Recent Studies (post-2010) (rhc 3164) | Studies (2-methylquinoxaline) | Trials (2-methylquinoxaline) | Recent Studies (post-2010) (2-methylquinoxaline) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 7 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, R; Jiang, X; Wu, K; Zhang, P; Zhang, Y | 1 |
1 review(s) available for rhc 3164 and 2-methylquinoxaline
| Article | Year |
|---|---|
Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities.
Topics: Animals; Anti-Allergic Agents; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Antiviral Agents; Drug Development; Heterocyclic Compounds; Humans; Hypoglycemic Agents; Mice; Neuroprotective Agents; Photochemotherapy; Quinoxalines; Structure-Activity Relationship; Tubulin Modulators | 2022 |